Additionally, a relevant problem in monitoring DTC patients is represented by the presence of thyroglobulin antibody (TgAb). TgAb is present in up to 15–25% of patients with DTC and may interfere on Tg immunoassays resulting in falsely low or undetectable Tg results [4]. In such cases, TgAb...